262 results
8-K
ACUR
Acura Pharmaceuticals, Inc
16 Aug 23
Termination of a Material Definitive Agreement
11:20am
through the Effective Date.
OXAYDO (previously known as OXECTA and ACUROX) was initially licensed in 2007 to King Pharmaceuticals Research … and Development, Inc. which was subsequently acquired by Pfizer, Inc. in 2011. The NDA for OXAYDO was approved by the US Food and Drug Administration in June
8-K
ACUR
Acura Pharmaceuticals, Inc
30 Jun 23
Results of Operations and Financial Condition
11:53am
with AD Pharma.
Research and development expense was $1.5 million for the twelve month period ended December 31, 2021, compared to $1.8 million
8-K
EX-99.1
ACUR
Acura Pharmaceuticals, Inc
30 Jun 23
Results of Operations and Financial Condition
11:53am
,
Revenues:
Royalties
Collaboration from related party
License fees from related party
Product sales
Total revenues
Operating expenses:
Research … and development
General and administrative
Total operating expenses
Operating loss
Gain on forgiveness of loans under CARES Act
Interest expense to related
8-K
EX-99.1
ACUR
Acura Pharmaceuticals, Inc
17 Nov 21
Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results
4:05pm
. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended … September 30, 2021 and 2020.
Research and development expense was $385 thousand for the third quarter 2021, compared to $519 thousand for the same period
8-K
EX-99.1
wwm5 si8i8lauqs2wc
17 Aug 21
Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results
6:50am
8-K
EX-99.1
y6oojf5anxz irqb8q
18 May 21
Acura Pharmaceuticals Announces About Acura Pharmaceuticals
4:05pm
8-K
EX-99.1
pyei8gabhq7e6gisxzvb
1 Apr 21
Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
4:15pm
8-K
EX-99.1
20z1ppa0
17 Nov 20
Acura Pharmaceuticals Announces Third Quarter 2020 Financial Results
4:10pm
8-K
EX-99.1
17p9hpvx r2u4
17 Aug 20
Acura Pharmaceuticals Announces Second Quarter 2020 Financial Results
6:05am
8-K
EX-99.1
8k6 9f8nn
30 Jun 20
Acura Pharmaceuticals Announces First Quarter 2020 Financial Results
4:14pm
8-K
EX-99.1
vwtrpdb oqjte2n4h
1 Apr 20
Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results
9:20am